Provenance Wealth Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2081584 FORT LAUDERDALE, FL

Position in GILD

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$330,884

-$33,429 QoQ

Shares Held

2,619

+0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#1,600

of 2,266 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Provenance Wealth Advisors, LLC holds $3,356,958 across 12 Drug Manufacturers - General names. GILD ranks #5 (9.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	5,052	$1,283,056
2	PFE	Pfizer Inc	17,084	$411,382
3	ABBV	AbbVie Inc.	1,565	$393,816
4	OGN	Organon & Co.	25,758	$348,763
5	GILD	Gilead Sciences, Inc. This page	2,619	$330,884
6	MRK	Merck & Co., Inc.	1,532	$196,862
7	AMGN	Amgen Inc	519	$187,940
8	NVS	Novartis AG	637	$99,830

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$330,884	2,619	+0.2%	Shares	Sole	2026-07-24
2026-03-31	$364,313	2,614	0.0%	Shares	Sole	2026-04-20
2025-12-31	$320,842	2,614	0.0%	Shares	Sole	2026-01-26
2025-09-30	$290,154	2,614	0.0%	Shares	Sole	2025-11-12
2025-06-30	$289,814	2,614	-0.9%	Shares	Sole	2025-08-15
2025-03-31	$295,699	2,639	-37.1%	Shares	Sole	2025-08-15
2024-12-31	$387,769	4,198	-74.7%	Shares	Sole	2025-08-15
2024-09-30	$1,389,228	16,570	+2.6%	Shares	Sole	2025-08-15
2024-06-30	$1,107,639	16,144	+3.0%	Shares	Sole	2025-08-15
2024-03-31	$1,147,974	15,672	+2.9%	Shares	Sole	2025-08-15
2023-12-31	$1,233,539	15,227	+1.5%	Shares	Sole	2025-08-15
2023-09-30	$1,124,624	15,007	—	Shares	Sole	2025-08-15
No filing history on record for this holder in this stock.